Mounjaro For Weight Loss
- All
- News
- Web Stories
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
"Lost Hair": Influencer Taking Mounjaro Explains First-Hand Effects Of Weight-Loss Drug
The influencer shared her harrowing experience with the medication and the severe side effects that left her struggling with hair thinning and muscle loss
-
After Aishwarya Mohanraj's 22 Kg Mounjaro Weight Loss Confession, Soha Ali Khan Says, "Takes Great Courage To Speak Truth"
Aishwarya Mohanraj recently made headlines after revealing that she lost 22 kg in six months
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Comedian Aishwarya Mohanraj Reveals How She Lost 22 Kg Using Weight Loss Drug: "World Is Built For Skinny Girls"
Comedian Aishwarya Mohanraj shared that she was insecure about her weight and double chin. She tried everything to lose weight before turning to Mounjaro
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Weight Regain Common Within Two Years After Stopping Weight Loss Injections, Finds Oxford Study
Participants regained their original weight within an average of 1.7 years after stopping any type of weight loss medication.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
"Lost Hair": Influencer Taking Mounjaro Explains First-Hand Effects Of Weight-Loss Drug
The influencer shared her harrowing experience with the medication and the severe side effects that left her struggling with hair thinning and muscle loss
-
After Aishwarya Mohanraj's 22 Kg Mounjaro Weight Loss Confession, Soha Ali Khan Says, "Takes Great Courage To Speak Truth"
Aishwarya Mohanraj recently made headlines after revealing that she lost 22 kg in six months
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Comedian Aishwarya Mohanraj Reveals How She Lost 22 Kg Using Weight Loss Drug: "World Is Built For Skinny Girls"
Comedian Aishwarya Mohanraj shared that she was insecure about her weight and double chin. She tried everything to lose weight before turning to Mounjaro
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Weight Regain Common Within Two Years After Stopping Weight Loss Injections, Finds Oxford Study
Participants regained their original weight within an average of 1.7 years after stopping any type of weight loss medication.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
